WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 581502

CAS#: 69587-11-7

Description: 4-Iodo-2,5-dimethoxybenzeneethanamine is discontined (DEA controlled substance). it is a psychoactive substances prevalent and sold as bath salt or research chemistry. Also, it is a N-2-methoxybenzyl-phenethylamines (NBOMe drugs).

Chemical Structure

CAS# 69587-11-7

Theoretical Analysis

MedKoo Cat#: 581502
Name: 4-Iodo-2,5-dimethoxy-beta-phenethylamine
CAS#: 69587-11-7
Chemical Formula: C10H14INO2
Exact Mass: 307.0069
Molecular Weight: 307.13
Elemental Analysis: C, 39.11; H, 4.59; I, 41.32; N, 4.56; O, 10.42

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: 4-Iodo-2,5-dimethoxy-beta-phenethylamine; 2C-I compound; Infinity; Isabel

IUPAC/Chemical Name: 4-Iodo-2,5-dimethoxy-beta-phenethylamine


InChi Code: InChI=1S/C10H14INO2/c1-13-9-6-8(11)10(14-2)5-7(9)3-4-12/h5-6H,3-4,12H2,1-2H3


Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 307.13 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Halberstadt AL. Pharmacology and Toxicology of N-Benzylphenethylamine ("NBOMe") Hallucinogens. Curr Top Behav Neurosci. 2017;32:283-311. doi: 10.1007/7854_2016_64. Review. PubMed PMID: 28097528.

2: Fink LH, Anastasio NC, Fox RG, Rice KC, Moeller FG, Cunningham KA. Individual Differences in Impulsive Action Reflect Variation in the Cortical Serotonin 5-HT2A Receptor System. Neuropsychopharmacology. 2015 Jul;40(8):1957-68. doi: 10.1038/npp.2015.46. Epub 2015 Feb 10. PubMed PMID: 25666313; PubMed Central PMCID: PMC4839520.

3: Armenian P, Gerona RR. The electric Kool-Aid NBOMe test: LC-TOF/MS confirmed 2C-C-NBOMe (25C) intoxication at Burning Man. Am J Emerg Med. 2014 Nov;32(11):1444.e3-5. doi: 10.1016/j.ajem.2014.04.047. Epub 2014 Apr 26. PubMed PMID: 24908444.

4: Halberstadt AL, Geyer MA. Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response. Neuropharmacology. 2014 Feb;77:200-7. doi: 10.1016/j.neuropharm.2013.08.025. Epub 2013 Sep 4. PubMed PMID: 24012658; PubMed Central PMCID: PMC3866097.

5: Stellpflug SJ, Kealey SE, Hegarty CB, Janis GC. 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine (25I-NBOMe): clinical case with unique confirmatory testing. J Med Toxicol. 2014 Mar;10(1):45-50. doi: 10.1007/s13181-013-0314-y. PubMed PMID: 23872917; PubMed Central PMCID: PMC3951642.

6: Bosak A, LoVecchio F, Levine M. Recurrent seizures and serotonin syndrome following "2C-I" ingestion. J Med Toxicol. 2013 Jun;9(2):196-8. doi: 10.1007/s13181-013-0287-x. PubMed PMID: 23378129; PubMed Central PMCID: PMC3657032.

7: Meyer MR, Maurer HH. Metabolism of designer drugs of abuse: an updated review. Curr Drug Metab. 2010 Jun 1;11(5):468-82. Review. PubMed PMID: 20540700.

8: Drees JC, Stone JA, Wu AH. Morbidity involving the hallucinogenic designer amines MDA and 2C-I. J Forensic Sci. 2009 Nov;54(6):1485-7. doi: 10.1111/j.1556-4029.2009.01199.x. PubMed PMID: 19878416.

9: Pichini S, Pujadas M, Marchei E, Pellegrini M, Fiz J, Pacifici R, Zuccaro P, Farré M, de la Torre R. Liquid chromatography-atmospheric pressure ionization electrospray mass spectrometry determination of "hallucinogenic designer drugs" in urine of consumers. J Pharm Biomed Anal. 2008 Jun 9;47(2):335-42. doi: 10.1016/j.jpba.2007.12.039. Epub 2008 Jan 4. PubMed PMID: 18262381.

10: Theobald DS, Pütz M, Schneider E, Maurer HH. New designer drug 4-iodo-2,5-dimethoxy-beta-phenethylamine (2C-I): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric and capillary electrophoretic/mass spectrometric techniques. J Mass Spectrom. 2006 Jul;41(7):872-86. PubMed PMID: 16810648.